Santa Cruz Biotechnology features a diverse variety of JAGN1 monoclonal antibodies for investigating JAGN1 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). JAGN1, or Jagunal homolog 1, regulates essential cellular processes, particularly in immune response and cellular stress. JAGN1 influences immune cell development and function, making it a significant focus in immunology research. Research on JAGN1 continues to reveal its importance in autoimmune diseases and infections. Scientists worldwide use JAGN1 monoclonal antibodies to explore cellular pathways and molecular mechanisms. Current studies highlight JAGN1's role in maintaining cellular homeostasis and immune system regulation. Ongoing research with JAGN1 monoclonal antibodies helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of immune system function and disease mechanisms.